O-linked β-N-acetylglucosamine signaling is highlighted as a molecular bridge connecting early brain development, adulthood, and aging, providing an integrated framework for understanding brain physiology and disease.
Abstract
ABSTRACT
Protein O-GlcNAcylation is a dynamic and reversible post-translational modification that functions as a central nutrient-sensing mechanism linking cellular metabolism to protein function. Controlled by the opposing activities of O-linked β-N-acetylglucosamine transferase and O-GlcNAcase, O-GlcNAcylation regulates thousands of nuclear, cytoplasmic, synaptic, and mitochondrial proteins involved in gene expression, neuronal differentiation, synaptic plasticity, proteostasis, mitochondrial homeostasis, and neuroimmune signaling. The brain exhibits particularly high O-linked β-N-acetylglucosamine activity, reflecting its exceptional metabolic demands and the need to rapidly couple nutrient availability with neuronal function. Emerging evidence demonstrates that precise regulation of O-linked β-N-acetylglucosamine cycling is indispensable throughout the lifespan, from embryonic neurodevelopment to healthy brain aging. Conversely, disruption of O-linked β-N-acetylglucosamine homeostasis caused by genetic defects, metabolic disturbances, or environmental stress contributes to neurodevelopmental disorders. In the aging brain, impaired glucose metabolism and insulin resistance reduce O-GlcNAcylation, promoting mitochondrial dysfunction, neuroinflammation, proteostasis failure, and the accumulation of pathogenic proteins. Consequently, dysregulated O-linked β-N-acetylglucosamine signaling has emerged as a convergent mechanism underlying brain disorders spanning neurodevelopment to neurodegeneration. Although clinical translation remains challenging, growing evidence supports O-GlcNAcylation as a master regulator of brain homeostasis and a promising therapeutic target for neurological disorders. Collectively, this review highlights O-linked β-N-acetylglucosamine signaling as a molecular bridge connecting early brain development, adulthood, and aging, providing an integrated framework for understanding brain physiology and disease.
This synthesis provides a framework for understanding how SUMOylation links metabolic stress to tissue-specific aging trajectories and therapeutic potential and evaluates emerging translational approaches that highlight both the opportunities and challenges of targeting SUMO-regulated stress responses in aging.
Xin-Yue Liu, Shuang Chen, Dong-Can Liu et al.· Ageing Research Reviews· 0 citations
It is shown that AT-1 overexpression impacts diverse phenotypes related to neuronal function and plasticity, and metabolic adaptation was coincident with decreased synaptic activity, indicating that neuronal communication is coordinated, in part, through acetyl-CoA metabolism.
Eric R. McGregor, C. McGill, N. Arp et al.· iScience· 0 citations
Pathogenic variants in O-GlcNAc transferase, which catalyses nucleocytoplasmic protein O-GlcNAcylation, cause a neurodevelopmental disorder (OGT-NDD) characterised by intellectual disability and motor impairments. However, mechanisms linking O-GlcNAc dyshomeostasis to brain development remain unclear. Longitudinal neur...
S. Almeida, S. Balasubramaniam, A. Jusiel et al.· medRxiv· 0 citations
Despite extensive characterization of cytosolic and nuclear acetylation, the functional relevance of luminal ER-Nε-lysine acetylation in the nervous system remains poorly understood. This modification is mediated by a coordinated metabolic-secretory axis involving acetyl-CoA availability and the ER-resident acetyltrans...
Emanuele Di Martino, R. A. de Vos, Sofia Koenig Gimeno et al.· Current Opinion in Chemical...· 0 citations
Background/Objectives: O-GlcNAcylation is a post-translational modification affecting diverse cell functions, including transcriptional regulation. Aberrant levels of protein O-GlcNAcylation have been observed in neurodegenerative and cardiovascular diseases. We have previously demonstrated that systemic elevation of p...
Margaret B. Bell, Gloria A. Benavides, Xiao-Sen Ouyang et al.· Journal of Molecular Patholo...· 0 citations
Subjects with diabetes have an increased risk of dementia, Parkinson's disease, and stroke. In the central nervous system, there is increased inflammation, blood-brain barrier permeability, amyloid-β and α-synuclein deposition, and decreased neuronal synaptogenesis and survival. The role of hexokinases in controlling g...
M. Alhujaily, N. Rabbani, Paul J Thornalley· Trends in endocrinology and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.